THNR vs. BELT ETF Comparison
Comparison of Amplify Weight Loss Drug & Treatment ETF (THNR) to BlackRock Long-Term U.S. Equity ETF (BELT)
THNR
Amplify Weight Loss Drug & Treatment ETF
THNR Description
The fund's manager invests at least 80% of its net assets (plus borrowings for investment purposes) in securities that comprise the index. The index is comprised of global companies who are manufacturers in the GLP-1 agonist pharmaceutical business or who enable such business. GLP-1 agonists (glucagon-like peptide) seek to lower blood sugar levels and reduce appetite and promote fullness, with the ultimate potential for weight loss. The fund is non-diversified.
Grade (RS Rating)
Last Trade
$23.15
Average Daily Volume
2,584
15
BELT
BlackRock Long-Term U.S. Equity ETF
BELT Description
Under normal circumstances, the fund invests at least 80% of its net assets, plus the amount of any borrowings for investment purposes, in equity securities of U.S. issuers and derivatives with similar economic characteristics. It may invest up to 20% of its assets in equity securities of foreign issuers, including ADRs and GDRs. The fund is non-diversified.Grade (RS Rating)
Last Trade
$30.36
Average Daily Volume
990
20
Performance
| Period | THNR | BELT |
|---|---|---|
| 30 Days | -11.31% | 1.17% |
| 60 Days | -15.54% | 1.28% |
| 90 Days | -17.09% | 2.70% |
| 12 Months |
THNR Underweight 18 Positions Relative to BELT
THNR: Top Represented Industries & Keywords
BELT: Top Represented Industries & Keywords
Compare ETFs
